Core Viewpoint - Kennedy-Wilson (KW) has shown a significant price increase of 11.3% over the past four weeks, with a mean price target of $9.9 indicating a potential upside of 32.7% from the current price of $7.46 [1] Price Targets and Analyst Consensus - The average price targets for KW range from a low of $7.70 to a high of $13.00, with a standard deviation of $2.76, suggesting variability in analyst estimates [2] - The lowest estimate indicates a 3.2% increase, while the highest suggests a 74.3% upside, highlighting the potential for significant price movement [2] - A low standard deviation among price targets indicates a high degree of agreement among analysts regarding the stock's price direction [9] Earnings Estimates and Market Sentiment - Analysts have shown increasing optimism about KW's earnings prospects, with a strong consensus on revising EPS estimates higher, which correlates with potential stock price increases [11] - The Zacks Consensus Estimate for the current year has risen by 245.5% over the past month, indicating positive sentiment among analysts [12] - KW holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, further supporting its potential upside [13] Caution on Price Targets - While price targets are commonly referenced by investors, they can often mislead, as empirical research shows that they rarely predict actual stock price movements accurately [7][10] - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8]

Market Outlook - Analysts predict the S&P 500 will increase by 7.5% in the next year [1] Investment Potential - Wall Street identifies companies with the most upside and downside potential [1]

Investors were assertively stepping on the gas pedal with Advance Auto Parts (AAP 5.41%) on Thursday. The stock closed more than 5% higher as of the 1 p.m. ET early market close for the Fourth of July holiday, a figure that was well higher than the S&P 500's (^GSPC 0.83%) 0.8% increase. An analyst price target raise had much to do with Advance's advance.A 16% price target hikeWell before market open that day, Mizuho prognosticator David Bellinger upped his fair-value assessment of Advance's stock. His new l ...

Core Viewpoint - Darling Ingredients (DAR) has shown a significant price increase of 23.2% over the past four weeks, with a mean price target of $52.69 indicating a potential upside of 38.9% from the current price of $37.94 [1] Price Targets and Analyst Estimates - The mean estimate consists of 13 short-term price targets with a standard deviation of $18.88, suggesting variability in analyst predictions. The lowest estimate is $34.00 (10.4% decline), while the highest is $110.00 (189.9% increase) [2] - Analysts' price targets can often mislead investors, as empirical research indicates that these targets rarely reflect actual stock price movements [7][10] - A low standard deviation among price targets indicates a high degree of agreement among analysts regarding the stock's price direction, which can serve as a starting point for further research [9] Earnings Estimates and Analyst Sentiment - Analysts are optimistic about DAR's earnings prospects, as indicated by a strong consensus in revising EPS estimates higher, which correlates with potential stock price increases [11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 1.4%, with one estimate moving higher and no negative revisions [12] - DAR holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, suggesting a solid potential upside [13] Conclusion on Price Movement - While the consensus price target may not be a reliable indicator of the extent of DAR's potential gains, the implied direction of price movement appears to be a useful guide for investors [14]

Shares of Upbound Group (UPBD) have gained 5% over the past four weeks to close the last trading session at $26.29, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $36.63 indicates a potential upside of 39.3%.The mean estimate comprises eight short-term price targets with a standard deviation of $8.07. While the lowest estimate of $26 indicates a 1.1% decline from the current pr ...

Natural Gas Services (NGS) closed the last trading session at $24.51, gaining 27.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $36.25 indicates a 47.9% upside potential.The mean estimate comprises four short-term price targets with a standard deviation of $5.97. While the lowest estimate of $32 indicates a 30.6% increase from the current price level, the most optimistic analys ...

Vertical Aerospace Ltd. (EVTL) closed the last trading session at $5.32, gaining 32% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $10.30 indicates a 93.6% upside potential.The average comprises five short-term price targets ranging from a low of $2 to a high of $15, with a standard deviation of $5.14. While the lowest estimate indicates a decline of 62.4% from the current price ...

European Wax Center, Inc. (EWCZ) closed the last trading session at $5.09, gaining 51.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $6.50 indicates a 27.7% upside potential.The average comprises eight short-term price targets ranging from a low of $4 to a high of $15, with a standard deviation of $3.51. While the lowest estimate indicates a decline of 21.4% from the current pr ...

Group 1 - Xperi (XPER) has shown a 7.3% increase in stock price over the past four weeks, with a mean price target of $18.25 indicating a potential upside of 134.3% [1] - The mean estimate includes four short-term price targets with a standard deviation of $8.02, suggesting variability in analyst predictions; the lowest estimate of $12 indicates a 54% increase, while the highest estimate suggests a 285.1% increase to $30 [2] - Analysts show strong agreement on XPER's ability to report better earnings than previously predicted, which supports the view of potential upside [4] Group 2 - The Zacks Consensus Estimate for XPER has increased by 46.2% over the past month, with no negative revisions, indicating positive earnings momentum [12] - XPER holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates, which is a strong indicator of potential upside [13] - While consensus price targets may not be reliable for predicting exact stock gains, they can provide a directional guide for price movement [13]

Spyre Therapeutics (SYRE) closed the last trading session at $15.55, gaining 6.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $53.50 indicates a 244.1% upside potential.The mean estimate comprises 10 short-term price targets with a standard deviation of $16.36. While the lowest estimate of $21 indicates a 35.1% increase from the current price level, the most optimistic analyst ...